4 results
The primary objective is to evaluate the safety and tolerability of the IntelliCap® system when used as a gastrointestinal fluid sampling device will be evaluated.Another primary aim is to evaluate the IntelliCap® system as a tool to study changes…
The overall objective is to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in male and femaleparticipants less than or equal to 6 months of age with IOPD.
The primary objective of the VertiGO! trial is to assess the feasibility of restoring vestibular function by making use of prolonged VI stimulation. This will be done using a combined VI and CI device: The CVI. To achieve this objective, patients…
Long-term safety and pharmacokinetics (PK) of neoGAA